| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |